请使用支持JavaScript的浏览器!
主营:分子类,蛋白类,抗体类,生化类试剂
℡ 4000-520-616
℡ 4000-520-616
Ancell/anti-CD16/100 g/165-520
产品编号:165-520
市  场 价:¥13900.00
场      地:美国(厂家直采)
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$695.00
品      牌: Ancell
公      司:Ancell
公司分类:
Ancell/anti-CD16/100 g/165-520
商品介绍

Human CD16 is a low affinity receptor for complexed IgG and occurs in two distinct forms, as a glycosyl phosphatidyl inositol (GPI) anchored protein in granulocytes, and as an integral membrane protein on NK cells and macrophages.

Isotype: Murine IgG1

Immunogen: Human polymorphonuclear leukocytes

Specificity: Antibody 3G8 recognizes both allelic forms of human CD16 (1, 4). It is cross reactive with cynomolgus (7) as well as Rhesus monkey(10) CD16.

Functional Application: Antibody 3G8 blocks binding of complexed IgG to CD16 (2, 5, 9), and has been used to block ADCC in Vitro (11).It is not suitable for Western blot. Ancell 3G8 F(ab‘2) has been used to upregulate Mac-1 expression in neutrophils (8).

References:

1. H.B. Fleit, et al, (1982) Proc Natl Acad Sci USA 79: 3275-3279.

2. Leukocyte Typing IV (W. Knapp, et al, eds.) Oxford University Press, Oxford, (1989) p. 574-597.

3. G. Trinchieri & N. Valiante, (1993) Natural Immunity 12: 218-234.

4. Leukocyte Typing V (S.F. Schlossman, et al, eds.) Oxford University Press, Oxford, (1995) p. 805-814.

5. J.C. Edberg & R.P. Kimberly, (1997) J Immunol 159: 3849-3857.

6. S. von Gunten, H.U. Simon, et al. (2006) Blood 108(13): 4255-4259.

7. Yoshino N, Honda M, et al. (2000) Exp Anim 49(2):97-110.

8. Z Xiao, S Neelamegham, et al. (2008) Blood 112: 1091-1100.

9. Laborde EA, M Vulcano, et al. (2007) J Immunol 179(1): 673-681.

10. Choi EI, Reimann KA, et al. (2008) Immunology 124(2): 215-22 PMID: 18201184

11. H Tanaka, M Yasukawa, et al. (2016) DOI: 10.1158/1078-0432 CCR-15-2714. PMID: 27091408

品牌介绍

Ancell世界著名的专注做人种属的流试抗体提供商。提供FITC、PE、APC、生物素和纯化human 抗体,可用于流式,FA 实验。并提供融合蛋白。

自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔